MS1819-SD
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
AzurRx SAS
Overview
MS1819-SD is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
MS1819-SD clinical trials
Explore related
Medical disclaimer. This page summarizes research about MS1819-SD for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.